Company Description
M3 (OTC Link: MTHRY) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $7.5B.
MTHRY has declined 27.7% over the past year. Shares last traded at $5.44.
This page collects what Stock Titan holds for MTHRY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
M3 (MTHRY) stock last closed at $5.44. Over the past 12 months, the stock has lost 27.7%. At a market capitalization of $7.5B, MTHRY is classified as a mid-cap stock with approximately 1.3B shares outstanding.
Latest News
M3 has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, acquisition, covid-19. View all MTHRY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in M3 (MTHRY) currently stands at 16.3 thousand shares, down 73.4% from the previous reporting period, representing 0.0% of the float. Since August 2025, short interest has increased by 86.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for M3 (MTHRY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.4 days.
MTHRY Company Profile & Sector Positioning
M3 (MTHRY) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MTHRY often look at related companies in the same sector, including Ping An Healthcare & Technolog (PIAHY), Raysearch Laboratories Ab (RSLBF), Kneat Com (KSIOF), Vitalhub (VHIBF), and Veradigm (MDRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MTHRY's relative position within its industry.